Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$221.61 USD
-3.14 (-1.40%)
Updated May 17, 2024 04:00 PM ET
After-Market: $221.60 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Brokerage Reports
Charles River Laboratories International, Inc. [CRL]
Reports for Purchase
Showing records 101 - 120 ( 379 total )
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Optimized Entry and Exit Levels for CRL 6122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Life Science, Bioproduction, CROs: Positive Data Points for 2023
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Expands CRADL Footprint; Adds 100bps of Revenue Tailwind
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Transferring Coverage of 5 Companies, Suspending Coverage of 16 Companies, Terminating Coverage of 1 Company
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Comprehensive Technical and Fundamental Analysis for CRL.
Provider: Stock Traders Daily
Analyst: Research Department